DIGEST Clinical Trials

107 recruitingLast updated: May 13, 2026

There are 107 actively recruiting digest clinical trials across 43 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Houston, Texas, United States, Dijon, France, London, United Kingdom. Updated daily from ClinicalTrials.gov.


DIGEST Trials at a Glance

107 actively recruiting trials for digest are listed on ClinicalTrialsFinder across 6 cities in 43 countries. The largest study group is Not Applicable with 42 trials, with the heaviest enrollment activity in Houston, Dijon, and London. Lead sponsors running digest studies include M.D. Anderson Cancer Center, Beijing Tiantan Hospital, and Mayo Clinic.

Treatments under study

About DIGEST Clinical Trials

Looking for clinical trials for DIGEST? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new DIGEST trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about DIGEST clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 107 trials

Recruiting
Not Applicable

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Carcinoma, HepatocellularLiver NeoplasmsAdenocarcinoma+2 more
Shanghai Zhongshan Hospital17 enrolled1 locationNCT06794073
Recruiting
Phase 2

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Unresectable Digestive System Neuroendocrine Tumor G1Unresectable Digestive System Neuroendocrine Tumor G2Metastatic Digestive System Neuroendocrine Tumor G1+1 more
National Cancer Institute (NCI)100 enrolled36 locationsNCT05773274
Recruiting
Not Applicable

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Esophageal CarcinomaGastric CarcinomaGastroesophageal Junction Carcinoma+7 more
Alliance for Clinical Trials in Oncology420 enrolled316 locationsNCT07283939
Recruiting
Not Applicable

Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints

Digestive HealthQuality of Life
Arizona State University114 enrolled1 locationNCT06946017
Recruiting
Not Applicable

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Colorectal, CancerColorectal NeoplasmsColorectal Polyp+2 more
Dartmouth-Hitchcock Medical Center8,946 enrolled22 locationsNCT05612347
Recruiting
Phase 1

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

Metastatic CancerGastrointestinal NeoplasmsGastrointestinal Diseases+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC278 enrolled31 locationsNCT05489237
Recruiting
Phase 2

Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia

Diabetes MellitusIndigestion
Mayo Clinic150 enrolled1 locationNCT03865290
Recruiting
Phase 3

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+7 more
NRG Oncology269 enrolled263 locationsNCT06500455
Recruiting
Phase 2

Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme

Colorectal, CancerDigestive Cancer
UNICANCER400 enrolled41 locationsNCT06475352
Recruiting
Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting

Product Surveillance Registry

Cardiac Rhythm DisordersDigestive disordersMinimally Invasive Surgical Procedures+13 more
Medtronic100,000 enrolled391 locationsNCT01524276
Recruiting

Comparing Traditional Risk Scores and an AI-Based Multimodal Model for Predicting Cardiovascular Events After Gastrointestinal Surgery

Cardiovascular DiseasesPostoperative ComplicationsDigestive System Surgical Procedures
Bach Mai Hospital5,000 enrolled1 locationNCT07539532
Recruiting

Molecular Epidemiology of Biliary Tree Cancers

CholangiocarcinomaMalignant Digestive System Neoplasm
M.D. Anderson Cancer Center1,500 enrolled1 locationNCT05179486
Recruiting
Phase 3

Domperidone in Treating Patients With Gastrointestinal Disorders

Nausea and VomitingGastroparesisDyspepsia+4 more
M.D. Anderson Cancer Center200 enrolled1 locationNCT01696734
Recruiting

AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases

AI (Artificial Intelligence)ImagingRadiology+1 more
First Affiliated Hospital, Sun Yat-Sen University5,000 enrolled1 locationNCT07087418
Recruiting

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Malignant Female Reproductive System NeoplasmMalignant Genitourinary System NeoplasmMalignant Digestive System Neoplasm
Wake Forest University Health Sciences500 enrolled59 locationsNCT07215624
Recruiting
Phase 1Phase 2

A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors

Her2-positive/Low-expression Urinary and Digestive Tract Tumors
Sichuan Baili Pharmaceutical Co., Ltd.42 enrolled1 locationNCT06031584
Recruiting
Not Applicable

Cancer Genetic Testing in Ethnic Populations

Breast CarcinomaHead and Neck CarcinomaMalignant Brain Neoplasm+8 more
Mayo Clinic1,800 enrolled2 locationsNCT04475640
Recruiting

Mayo Clinic Upper Digestive Disease Survey

Esophageal CancerEsophagus CancerEsophageal Neoplasms+6 more
Mayo Clinic1,000 enrolled1 locationNCT02530983
Recruiting
Not Applicable

EUS-guided RFA for Solid Abdominal Neoplasms

Digestive System Neoplasms
Chinese University of Hong Kong30 enrolled1 locationNCT03221335